Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells

K. Tsuji, S. Yamamoto, W. Ou, N. Nishi, I. Kobayashi, M. Zaitsu, E. Muro, Y. Sadakane, T. Ichimaru, Y. Hamasaki
European Respiratory Journal 2005 26: 795-803; DOI: 10.1183/09031936.05.00010805
K. Tsuji
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Yamamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Ou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Nishi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Kobayashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Zaitsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Muro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Sadakane
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Ichimaru
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Hamasaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The exacerbation of asthma during viral infections is mainly explained by neutrophils infiltrating into the airways. However, enhanced functions of eosinophils are also observed. The aim of this study was to reveal the mechanism of how eosinophils are activated during and after viral infection of the airways, using a model of viral infection.

A synthetic double-stranded RNA, poly inosinic-cytidyric acid (poly(IC)), was transfected to a human airway epithelial cell line (BEAS-2B) and the primary bronchial epithelial cells, to mimic a viral infection. The production of chemokines from the cells was investigated.

The transfection of poly(IC), alone, marginally affected the eotaxin-3 production of the cells. However, the transfection of poly(IC) prior to interleukin (IL)-4 stimulation enhanced eotaxin-3 production. Poly(IC) transfection increased mRNA and protein expressions of IL-4 receptor (R)α and IL-2Rγ, components of the IL-4R. In BEAS-2B cells, IL-4-mediated phosphorylation of signal transducer and activator of transcription six was enhanced in poly(IC) transfected cells. This was reversed by the addition of anti-IL-4Rα antibody, suggesting the role of an increased number of IL-4 receptors in enhanced IL-4-induced eotaxin-3 production. Poly(IC)-induced upregulation of IL-4Rα was inhibited by treatment with cycloheximide or dexamethasone.

In conclusion, these results suggest that viral airway infection may enhance interleukin-4-induced eotaxin-3 production through upregulation of the interleukin-4 receptor in airway epithelial cells.

  • Airway epithelial cells
  • double-stranded RNA
  • eotaxin-3
  • interleukin-4 receptor

Bronchial epithelial cells were previously considered to function merely as a barrier to the external environment. However, accumulating evidence has revealed that the cells participate in airway inflammation through the production of a wide range of mediators, including chemokines 1. Eotaxins are a class of these chemokines. Three eotaxins have been demonstrated: eotaxin-1, -2 and -3, which are also referred to as chemokine ligand (CCL)11, CCL24 and CCL26, respectively 2–4. These eotaxins show potent chemoattractant activity toward eosinophils and are, thus, believed to play an important role in the pathogenesis of bronchial asthma 5. The combined stimulation of tumour necrosis factor-α and interleukin (IL)-4 has been observed to induce eotaxin-1 in cultured bronchial epithelial cells 6. The cells also produce eotaxin-3 when stimulated with IL-4 or IL-13 7. A study by Berkman et al. 8 demonstrated an increased mRNA expression of eotaxin-3, but not eotaxin-1, in the airway of asthmatic subjects after an allergen challenge. This suggested the important role of eotaxin-3 in late-phase asthmatic response.

The exacerbation of bronchial asthma is often associated with viral airway infections, including rhinovirus (RV) and respiratory syncytial virus (RSV) 9, 10. Bronchial epithelial cells have been reported to produce IL-8 and RANTES in response to RV infection 11, 12. Thus, bronchial epithelial cells play an important role in recruiting neutrophils and T-lymphocytes into the airways during viral infection. Viral associated wheeze has been demonstrated to be characterised by neutrophilic inflammation in both the upper and lower respiratory tracts without eosinophilia 13. However, there are several pieces of evidence which also demonstrate the involvement of other inflammatory cells, e.g. eosinophils in the airways during viral infection. The increased production of eotaxin-1 after viral infection has previously been demonstrated 14. RV infection upregulates eotaxin-1 and eotaxin-2 expression in the bronchial epithelial cells 15. Leukotriene C4 within upper airway secretions in infants with RSV bronchiolitis is likely to originate from the eosinophils 16. It has been suggested that eotaxin-3 is specifically involved in late-phase asthmatic response, facts which may not fully explain the exacerbation of asthma during or after viral airway infection. Currently, no information is available on whether eotaxin-3 is upregulated or not during viral infection. Thus, it was hypothesised by the current authors that viral airway infection may increase the eotaxin-3 production of the bronchial epithelial cells, and possibly result in the exacerbation of bronchial asthma in ongoing asthmatic patients.

As a direct result of this hypothesis the effects of double-stranded (ds) RNA on IL-4-induced eotaxin-3 production in cultured human bronchial epithelial cells, including primary cells, was investigated in vitro. The current work, presented in this paper, investigates the possibility that viral airway infections may trigger subsequent allergen-induced airway eosinophilia, in which the upregulation of the IL-4 receptor (IL-4R) by dsRNA plays an important role in the production of eotaxin-3 in airway epithelial cells.

MATERIALS AND METHODS

Cells

The human bronchial epithelial cell line BEAS-2B, was obtained from the American Type Culture Collection (Manassas, VA, USA). Primary cultured normal human bronchial epithelial (NHBE) cells were obtained from Clonetics (Walkersville, MD, USA). Both cells were cultured as previously described 17.

Transfection of dsRNA to the cells

BEAS-2B and NHBE cells (4×105· well−1) were seeded onto six-well plates 24 h before transfection. Transfection was carried out using Effectene reagent (QIAGEN, Valencia, CA, USA) according to the manufacturer's instruction. In brief, graded doses of poly inosinic-cytidyric acid (poly(IC); Sigma-Aldrich, St. Louis, MO, USA), a synthetic dsRNA, prepared in 1 μL of water were mixed into the reagent and Dulbecco's Modified Eagles Medium. For the control, 100 ng·well−1 of poly deoxyinosinic-deoxycytidyric acid (dIdC; Sigma-Aldrich), a synthetic dsDNA, or 100 ng·well−1 of poly inosinic acid (poly(I); Sigma-Aldrich), a synthetic single-stranded RNA, was used. Cells were incubated at 37°C for 24, 48 or 72 h depending on the experiment. After 24 h of transfection, the transfection reagent was removed by washing the cells with PBS.

Stimulation of the cells

To induce eotaxin-3 production, cells were stimulated with 50 ng·mL−1 of either IL-4 or IL-13 (Peprotec, London, UK) for 24 h. At the time of transfection, 20 µg·mL−1 of cycloheximide (CHX; Sigma-Aldrich) or varying concentrations of dexamethasone (DEX; Sigma-Aldrich) were added to the culture medium. CHX or DEX was removed 24 h after transfection. To antagonise the action of IL-4R, cells were pre-treated with 20 µg·mL−1 of mouse antihuman IL-4Rα (Immunotech, Marseille, France) for 15 min, and then stimulated with IL-4. The antibody used was a blocking antibody 18. Mouse anti-immunoglobulin G1 was used as control.

RT-PCR

Total RNA was extracted from the cells as previously described 19. RT-PCR was performed by the conventional method. Sequences of the primers are shown in table 1⇓. PCR settings were as follows for eotaxin-3, β-actin, IL-4Rα, IL-2Rγ and IL-13Rα1: first denaturing at 94°C for 2 min, then denaturing at 94°C for 30 s, annealing at 58°C for 30 s, extending at 72°C for 30 s, and finally extension at 72°C for 2 min. RANTES and IL-8 were annealed at 56°C and 50°C, respectively. For eotaxin-3, 28 cycles of amplification were performed for semiquantitative comparison because the amount of PCR products reached a plateau after 32 cycles (data not shown). For RANTES, IL-8, β-actin, IL-4Rα, IL-2Rγ and IL-13Rα1, 32, 32, 22, 36, 38 and 30 cycles were performed, respectively. The PCR cycles were determined by densitometrical analyses, as previously described 20.

View this table:
  • View inline
  • View popup
Table. 1—

Primers sequences used for RT-PCR

Measurement of protein release in culture medium

RANTES, IL-8 and eotaxin-3 released into culture medium were measured by ELISA (BioSource, Camarillo, CA, USA, for RANTES and IL-8; R&D systems, Minneapolis, MN, USA, for eotaxin-3). The minimum detectable doses of RANTES, IL-8 and eotaxin-3 were 3.0 pg·mL−1, 5.0 pg·mL−1 and 2.3 pg·mL−1, respectively.

Flow cytometry

Flow cytometry analyses for the detection of IL-4Rα and IL-2Rγ was performed as previously described 20.

Immunoblotting

Total cellular protein was prepared 24 h post transfection, as previously described 20. Immunoblotting for signal transducer and activator of transcription (STAT)6 and phosphorylated STAT6 was carried out using anti-STAT6 (#sc-621; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) and anti-p-STAT6 (#sc-11762-R; Santa Cruz), respectively, as previously described 20.

Statistical analysis

Data are presented as means±sd. The significance of the differences was evaluated by ANOVA, and multiple pairwise comparisons were carried out with the Fischer test in the analysis of protein productions of RANTES, IL-8 and eotaxin-3, and in the analysis of mean fluorescence intensity values in flow cytometry experiments. In the experiments investigating IL-4Rα mRNA expression, data were analysed by ANOVA on ranks. A p-value of <0.05 was considered statistically significant.

RESULTS

Effects of poly(IC) on the productions of chemokines

The effects of poly(IC) on the productions of chemokines from BEAS-2B cells were initially investigated. Poly(IC), but not poly(I), induced RANTES and IL-8 production, as previously described (fig. 1a⇓ and b) 21, 22. A small, yet significant increase in eotaxin-3 production was observed when transfected with 1 ng·well−1 or 10 ng·well−1 of poly(IC) (fig. 1c⇓). Dose-dependent enhancement of the mRNA expressions of RANTES and IL-8 was observed, although no apparent induction of eotaxin-3 mRNA expression was detected when amplified to 28 PCR cycles (fig. 1d⇓; gel shown is representative of results from three experiments). Eotaxin-3 mRNA was detected when amplified to 32 PCR cycles. Although the abundance of exotaxin-3 mRNA in poly(IC) transfected cells (10 ng·well−1) was greater than that observed in nontransfected cells, the difference was not statistically significant (p = 0.07; data not shown).

Fig. 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1—

BEAS-2B cells were transfected with increasing doses of poly inosinic-cytidyric acid (poly(IC); ░) or 100 ng·well−1 of poly inosinic acid (poly(I); Embedded Image) and incubated for 24 h. The concentrations of a) RANTES, b) interleukin (IL)-8 and c) eotaxin-3 released into the culture medium were determined by ELISA. Results shown are means±sd of values from three separate experiments. **: p<0.01 compares the value in poly(I) transfected cells. d) RANTES, IL-8 and eotaxin-3 mRNA expressions were investigated by RT-PCR.

Transfection of poly(IC) enhanced IL-4-induced eotaxin-3 production

Stimulation with IL-4 or IL-13 induces eotaxin-3 production in BEAS-2B cells 7, 17. The effects of poly(IC) transfection on IL-4- or IL-13-induced eotaxin-3 production were also investigated. BEAS-2B cells were transfected with increasing doses of poly(IC), IL-4 (50 ng·mL−1) stimulation was started simultaneously and incubation was for 24 h. No significant enhanced IL-4-induced eotaxin-3 production was observed (fig. 2a⇓, white column). However, 48 h post-incubation with poly(IC) transfection, prior to IL-4 stimulation (50 ng·mL−1 for 24 h), allowed significant enhanced eotaxin-3 production in a dose-dependent manner (fig. 2a⇓, grey column). Figure 2b⇓ shows the effects of 100 ng·well−1 of poly(IC) transfection on IL-4- or IL-13-induced eotaxin-3 production. Cells were incubated for 48 h, then stimulated with or without 50 ng·mL−1 of either IL-13 or −14 for 24 h. Small, yet significant enhanced IL-4-induced eotaxin-3 production was observed in the cells transfected with poly(I) when compared with those in the cells without transfection. The IL-4-induced eotaxin-3 production was dramatically enhanced in poly(IC) transfected cells. IL-13-induced eotaxin-3 production was also significantly increased in poly(IC) transfected cells; however, the increase was smaller than observed in IL-4-induced production (a 3.3-fold increase in IL-4-induced production versus a 1.2-fold increase in IL-13-induced production). The effect of poly(I) and poly(IC) transfection on IL-4-induced eotaxin-3 production in NHBE cells was also investigated (fig. 2c⇓). The NHBE cells were stimulated with or without 50 ng·mL−1 of IL-4, 2 days after transfection. Cells were then incubated for an additional 24 h. No eotaxin-3 was detected in the cells transfected with either poly(I) or poly(IC) if the cells were not stimulated with IL-4 (data not shown). IL-4 induced eotaxin-3 production in NHBE cells, as previously described 18. IL-4-induced eotaxin-3 production was significantly higher in poly(IC) transfected cells. In contrast, transfection of poly(I) had no significant effect (fig. 2c⇓).

Fig. 2—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2—

a) Effects of poly inosinic-cytidyric acid (poly(IC)) transfection on interleukin (IL)-4-induced eotaxin-3 production. BEAS-2B cells were incubated as indicated. ▪: cells incubated without any stimulation; □: cells were transfected with varying doses of poly(IC) at the time of stimulation; ░: cells were incubated for 48 h after transfection with varying doses of poly(IC). Results shown are means±sd of values from three separate experiments. b) BEAS-2B cells with no transfection (□), poly inosinic acid (poly(I)) transfection (100 ng·well−1; Embedded Image), or poly(IC) transfection (100 ng·well−1; ░). Results shown are means±sd of values from four separate experiments. c) IL-4-induced eotaxin-3 production in normal human bronchial epithelial (NHBE) cells that were nontransfected (□) or were transfected with 100 ng·well−1 of either poly(I) (Embedded Image) or poly(IC) (░), and incubated for 48 h. Results shown are means±sd of values from triplicate samples.*: p<0.05 **: p<0.01. In all cases, the amount of eotaxin-3 released in the culture medium was determined by ELISA. Methods are provided in greater detail in the main text.

Poly(IC) enhanced expression of IL-4R complex

Receptor regulation is one of the most important mechanisms for determining the functions of the ligands, including cytokines. Therefore, the effect of dsRNA on the expression of components of IL-4R complexes was investigated. It was observed that the transfection of poly(IC) upregulated IL-4Rα mRNA expression, in a dose-dependent manner (fig. 3a⇓). mRNA expression of IL-2Rγ (not observed before transfection) was induced by transfection of poly(IC) (fig. 3a⇓). However, the transfection of poly(IC) had no apparent effect on IL-13Rα1 mRNA expression (fig. 3a⇓). IL-4Rα and IL-2Rγ protein expressions at the surface of BEAS-2B cells were further investigated by flow cytometry. Transfection of poly(IC), followed by a 2-day incubation period was found to enhance both IL-4Rα and IL-2Rγ protein expressions at the cell surface when compared with those in the cells transfected with poly(I) (figs. 3b and c⇓). Table 2⇓ shows dose-dependent induction of IL-4Rα and IL-2Rγ protein expressions in BEAS-2B cells. Although transfection with poly(I) or poly(dIdC) also induced the increase in IL-4Rα protein expressions, the current authors postulated that it was the effect of the transfection reagent because the transfection reagent itself induced a significant increase in IL-4Rα protein expression. A time-dependent increase in IL-4Rα expression at the cell surface was also observed (fig. 3d⇓).

Fig. 3—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3—

a) Effects of poly inosinic-cytidyric acid (poly(IC)) transfection on the mRNA expression of components of interleukin (IL)-4 receptor (R). BEAS-2B cells were transfected with transfection reagent alone, varying doses of poly(IC) or 100 ng·well−1 of poly inosinic acid (poly(I)). The results presented are from one of three experiments which produced similar results. b) IL-4Rα and c) IL-2Rγ expressions at the cell surface in BEAS-2B cells investigated by flow cytometry analysis using mouse anti-human IL-4Rα or rat anti-human IL-2Rγ, respectively. Cells were incubated for 48 h after transfection of either poly(I) (═) or poly(IC) (–––). ▒ cells not transfected. d) Time kinetics of IL-4Rα protein expression. After transfection with 100 ng·well−1 of poly(IC), BEAS-2B cells were incubated for 24 (– – –), 48 (═) and 72 h (–––). e) IL-4Rα and f) IL-2Rγ expression at the cell surface in normal human bronchial epithelial (NHBE) cells. NHBE cells were incubated for 48 h after transfection of either poly(I) or poly(IC). ▒: cells not transfected. – – –: cells transfected with 100 ng·well−1 of poly(I); –––: cells transfected with 100 ng·well−1 of poly(IC); ═: nontransfected cells labelled with isotype-matched mouse immunoglobulin (Ig)G (e) or isotype-matched rat IgG (f). The results presented are from one of two experiments which produced similar results.

View this table:
  • View inline
  • View popup
Table. 2—

Effect of transfection on interleukin(IL)-4-receptor (R)α and IL-2Rγ expression at the cell surface in BEAS-2B cells

A significant upregulation of protein expression of both IL-4Rα and IL-2Rγ at the cell surface by the transfection of poly(IC) was also observed in NHBE cells. The histograms in figures 3e and f⇑ show that NHBE cells include at least two cell populations. IL-4Rα and IL-2Rγ proteins were upregulated in both these populations by transfection with poly(IC). Upregulation of IL-4Rα and IL-2Rγ mRNA expression was also observed (data not shown).

Cycloheximide inhibited poly(IC)-induced enhancement of IL-4Rα

The effect of CHX, an inhibitor of protein synthesis, on IL-4R protein expression at the cell surface in BEAS-2B cells was investigated. When the cells were cultured with CHX, the constitutive expression of IL-4Rα at the cell surface was significantly inhibited. Poly(IC) transfection-induced IL-4Rα protein expression was also inhibited by CHX to a similar degree (fig. 4⇓). These results indicate the role of de novo protein synthesis in IL-4Rα production by the transfection of poly(IC).

Fig. 4—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4—

Effect of cycloheximide (CHX) on poly inosinic-cytidyric acid (poly(IC))-induced interleukin (IL)-4 receptor(R)α expression at the cell surface in BEAS-2B. At the time of transfection of poly(IC), 20 µg·mL−1 of CHX was added (100 ng·well−1). After 48 h of culture, those cells were subjected to fluorescence-activated cell sorter analysis. ▒: constitutive IL-4Rα expression; –––: IL-4Rα expression in the cells transfected with poly(IC); – – –: cells cultured with CHX after transfection of poly(IC); ═: cells cultured with CHX without transfection. The results presented are from one of two experiments which produced similar results.

Transfection of poly(IC) induced increased IL-4-mediated cellular signal

To investigate whether increased expression of IL-4R results in increased IL-4-mediated signal, the effect of poly(IC) transfection on IL-4-induced activation of STAT6 in BEAS-2B cells was investigated. Both IL-4- and IL-13-induced phosphorylation of STAT6 were enhanced in poly(IC) transfected cells when compared with those in nontransfected cells (figures 5a⇓ and b). The addition of anti-IL-4Rα antibody inhibited IL-4-induced phosphorylation of STAT6 in poly(IC) transfected cells as well as in poly(I) transfected cells (fig. 5c⇓). It was also observed that anti-IL-4Rα completely inhibited IL-4-induced eotaxin-3 production in poly(IC) transfected cells (data not shown). These results suggest that IL-4-induced eotaxin-3 production was totally IL-4R dependent, and that poly(IC) increased the number of IL-4R at the cell surface, thus enhancing the IL-4-mediated signal in BEAS-2B cells.

Fig. 5—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5—

a and b) Effects of poly inosinic-cytidyric acid (poly(IC)) transfection on interleukin (IL)-4- or IL-13-induced signal transducer and activator of transcription (STAT)6 activation in BEAS-2B cells. Cells were transfected with transfection reagent alone or with poly(IC) (100 ng·well−1), followed by a 48-h incubation. The cells were then incubated with or without 50 ng·mL−1 of either IL-13 or IL-4, for 30 min. Cell lysate samples were analysed by immunoblotting for STAT6 and p-STAT6, as described in the Materials and Methods section. The result presented is one from two experiments which produced similar results. c) BEAS-2B cells were transfected with 100 ng·mL−1 of either poly(IC) or poly inosinic acid (poly(I)), and incubated for 48 h. Those cells were treated with 20 µg·mL−1 of anti-IL-4Rα for 15 min before stimulation with 50 ng·mL−1 of IL-4 for 30 min. Cell lysate samples were subjected to immunoblotting analysis. The result presented is one from two experiments which produced similar results.

Effects of glucocorticoid on poly(IC) induced IL-4Rα mRNA expression

The effects of DEX on the poly(IC)-induced increase of IL-4Rα mRNA expression in BEAS-2B cells was investigated. An attenuation of poly(IC)-induced IL-4Rα mRNA expression by DEX was observed (figs 6a and b⇓). Flow cytometry analysis, which was performed 48 h after transfection, showed significant attenuation of poly(IC)-induced IL-4Rα expression by DEX in a dose-dependent manner (table 3⇓). However, DEX had no effect on the constitutive or poly(I)-induced expression of IL-4Rα (table 3⇓). Figure 6c⇓ shows the effect of DEX plus poly(IC) on IL-4-induced eotaxin-3 production. In spite of the removal of DEX by washing the cells 24 h before IL-4 stimulation, DEX treatment attenuated IL-4-induced eotaxin-3 production, both in the cells transfected with poly(I) and in the cells transfected with poly(IC). However, there was no significant difference in eotaxin-3 production between the cells treated with DEX plus poly(I) and the cells treated with DEX plus poly(IC). These results suggest that DEX treatment attenuated poly(IC)-induced IL-4R expression, thus causing the attenuation of IL-4-induced eotaxin-3 production.

Fig. 6—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6—

a) Effect of dexamethasone (DEX) on poly inosinic-cytidyric acid (poly(IC))-induced interleukin (IL)-4 receptor (R)α mRNA expression in BEAS-2B cells. Varying doses of DEX were added at the time of transfection of poly(IC) (100 ng·well−1), and incubated for 24 h. Cells were then subjected to RT-PCR analysis. IL-4Rα mRNA expression is expressed as a ratio of β-actin mRNA expression. Results shown are means±sd of values from three separate experiments. b) An ethidium bromide-stained agarose gel shown as a representative of results obtained from three experiments. c) BEAS-2B cells transfected with either 100 ng·well−1 of poly inosinic acid or poly(IC) with or without DEX (10−6 M) were incubated for 24 h, then the cells were washed with PBS. The cells were stimulated 48 h after transfection with IL-4 (50 ng·mL−1) for 24 h. The amount of eotaxin-3 released into the culture medium was determined by ELISA. Results shown are means±sd of values from triplicate samples. *: p<0.05, **: p<0.01.

View this table:
  • View inline
  • View popup
Table. 3—

Effect of dexamethasone(DEX) on poly inosinic-cytidyric acid (poly(IC))-induced interleukin (IL)-4 receptor (R)α expression at the cell surface of BEAS-2B cells

DISCUSSION

There has been increasing interest in the relationship between bronchial asthma and various viral infections, particularly RV and RSV 10, 23. These viruses are often associated with the exacerbation of asthma, both in children and in adults 24–26. RV RNA or transfection of synthetic dsRNA into an airway epithelium has been shown to induce the production of several chemokines, including IL-8 and RANTES, which contribute to the recruitment of neutrophils and activated lymphocytes into the airways 21, 27. The current study also confirmed the induction of these chemokines by a synthetic dsRNA, poly(IC), in the bronchial epithelial cell line BEAS-2B. Thus, chemokines such as IL-8 and RANTES secreted from the airway epithelium are believed to play an important role in the exacerbation of bronchial asthma.

In the current study, the question was postulated whether dsRNA treatment could induce eotaxin-3 production in bronchial epithelial cells. Eotaxins-1 and -2 were demonstrated to be upregulated in viral airway infection 15. In BEAS-2B cells, a small amount of eotaxin-3 was induced by the transfection of poly(IC). However, eotaxin-3 was not induced in NHBE cells. Although it is still obscure, the viral infection itself might not have a potent effect on eotaxin-3 production in airway epithelial cells.

The current authors raised the question of whether an airway viral infection might enhance subsequent allergic response. Allergen challenge performed after RV inoculation showed a significantly greater increase in the nasal output of eosinophil peroxidase when compared with that performed before inoculation 28. In the present study, dsRNA transfection prior to IL-4 stimulation enhanced eotaxin-3 production in both BEAS-2B and NHBE cells. Recently, it has been demonstrated that pre-treatment with interferon (IFN)-γ enhanced IL-4-induced eotaxin-3 production, though costimulation with IFN-γ and IL-4 suppressed eotaxin-3 production in BEAS-2B cells 20. Since IFN-γ is abundantly produced in a virus-infected airway, the current authors speculated that viral airway infection might sensitise the airway epithelial cells and enhance allergen-induced response, which might result in airway eosinophilia 20. These combined observations suggest that viral infections of the airway might trigger subsequent allergen-induced airway eosinophilia in ongoing asthmatic patients.

Airway epithelial cells express two types of IL-4 receptors, type 1 and type 2 IL-4Rs 17, 20, 29. To the current authors' knowledge, this is the first study to report that the transfection of dsRNA enhances the expression of IL-4Rα and IL-2Rγ, components of type 1 IL-4R, in airway epithelial cells. IL-4Rα protein has been demonstrated to be synthesised de novo. The results indicate that the enhanced IL-4-induced eotaxin-3 production in poly(IC) transfected cells was due to the upregulation of IL-4R expression at the cell surface. The results that poly(IC) enhanced IL-4R-mediated p-STAT6 generation, and that anti-IL-4R antibody inhibited p-STAT6 generation in the poly(IC) transfected cells as well as in poly(I) transfected cells, also support the increased number of IL-4R expression at the cell surface.

The current study demonstrates that the transfection of poly(IC)-induced IL-4Rα expression of both mRNA and protein levels was attenuated by DEX. This is the first study that demonstrates the regulation of IL-4Rα expression by glucocorticoid in airway epithelial cells, although DEX was demonstrated to inhibit IL-4-induced IL-4Rα upregulation by translational or post-translational mechanisms in isolated T- and B-lymphocytes 30. Since the constitutive expression of IL-4Rα protein was observed not to be affected by DEX, DEX may interfere with transcription factors induced only by dsRNA, and not with those required for constitutive IL-4R gene expression. IL-4-induced eotaxin-3 production was attenuated by DEX treatment even in the cells transfected with poly(I). This may be inconsistent with the current observation that the constitutive expression of IL-4Rα protein was not affected by DEX. Since DEX itself strongly inhibits IL-4-induced eotaxin-3 production 17, the effect of DEX may still have remained at the time of IL-4 stimulation in this experiment. These results suggest that topical glucocorticoid therapy may influence the course of allergic and inflammatory processes during viral infection by downregulating the expression of IL-4Rα and the IL-4R-mediated production of chemokines, including eotaxin-3, of the airway epithelial cells.

It has been demonstrated that dsRNA interacts with at least two independent cellular systems, in which dsRNA-dependent protein kinase (PKR) and 2′–5′-linked oligoadenylate synthase are involved 22, 31. The activation of nuclear factor (NF)-κB and mitogen-activated protein kinase (MAPK) pathways, including p38 MAPK and c-Jun N-terminal kinase, has been demonstrated to be involved in dsRNA-dependent cellular signalling 20, 32. In airway epithelial cells, the activation of PKR, NF-κB and the p38 MAPK pathway was demonstrated by incubation with poly(IC) or transfection of viral RNA 21, 22. In BEAS-2B cells, it was recently observed that inhibitors of the MAP and ERK (extracellular signal-regulated kinase) kinase (MEK)1/2 MAPK pathway, in addition to inhibitors of the NF-κB and p38 MAPK pathway, inhibited poly(IC)-induced IL-4Rα gene expression (unpublished observation). Several pathways, including MEK1/2 MAPK, may be involved in signal transduction pathways leading to IL-4Rα gene expression in airway epithelial cells.

In summary, the current study demonstrates that the transfection of poly inosinic-cytidyric acid enhanced interleukin-4-induced eotaxin-3 production in airway epithelial cells, although poly inosinic-cytidyric acid itself showed only marginal effects on eotaxin-3 production. The upregulation of type 1 interleukin-4 receptor was involved in the mechanism of increasing eotaxin-3 production. Topical steroid therapy might decrease virus-induced interleukin-4 receptor expression, and, thus, be effective for asthmatic patients. These results might explain the relationship between viral airway infections and the exacerbation of bronchial asthma. Since the current study is only a model of viral infection, which may not perfectly reflect in vivo interactions, further study is needed to confirm the results by using real viruses or an in vivo model of a viral infection.

Acknowledgments

The authors would like to thank M. Ozeki for her technical assistance.

  • Received January 31, 2005.
  • Accepted July 10, 2005.
  • © ERS Journals Ltd

References

  1. ↵
    Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002;38:881–885.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2:449–456.
    OpenUrlCrossRefPubMedWeb of Science
  3. Forssmann U, Uguccioni M, Loetscher P, et al. A novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophile leukocytes. J Exp Med 1997;185:2171–2176.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Kitaura M, Suzuki N, Imai T, et al. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem 1999;274:27975–27980.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Rojas-Ramos E, Avalos AF, Perez-Fernandez L, Cuevas-Schacht F, Valencia-Maqueda E, Teran LE. Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma. Eur Respir J 2003;22:310–316.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Matsukura S, Stellato C, Georas SN, et al. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol 2001;24:755–761.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Komiya A, Nagase H, Yamada H, et al. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. Cellular Immunol 2003;225:91–100.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    Berkman N, Ohnona S, Chung FK, Breuer R. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol 2001;24:682–687.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995;310:1225–1229.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Gern JE. Rhinovirus respiratory infections and asthma. Am J Med 2002;112: Suppl. 6a 19S–27S.
    OpenUrl
  11. ↵
    Subauste MC, Jacoby DB, Richard SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995;96:549–557.
  12. ↵
    Schroth MK, Grimm E, Frindt P, et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol 1999;20:1220–1228.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    Mackean MC, Hewitt C, Lambert PC, Myint S, Silverman M. An adult model of exclusive viral wheeze: inflammation in the upper and lower respiratory tracts. Clin Exp Allergy 2003;33:912–920.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Weinberg JB, Lutzke ML, Efstathiou S, Kunkel SL, Rochford R. Elevated chemokine responses are maintained in lungs after clearance of viral infection. J Virol 2002;76:10518–10523.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Papadopoulos NG, Papi A, Meyer J, et al. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy 2001;31:1060–1066.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    Dimova-Yaneva D, Russell D, Main M, Brooker RJ, Helms PJ. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy 2004;34:555–558.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    Kobayashi I, Yamamoto S, Nishi N, et al. Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of IL-4 receptor and nuclear factor-kappaB. Ann Allergy Asthma Immunol 2004;93:390–397.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Zurawski SM, Chomarat P, Djossou O, et al. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 1995;270:13869–13878.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Yamamoto S, Hamasaki Y, Ishii E, Ichimaru T, Miyazaki S. Unbalanced production of interleukin-5 and interleukin-2 in children with atopic dermatitis. Ann Allergy Asthma Immunol 1997;78:517–523.
    OpenUrlPubMedWeb of Science
  20. ↵
    Yamamoto S, Kobayashi I, Tsuji K, et al. Upregulation of IL-4R by IFN-γ; enhanced IL-4-induced eotaxin-3 production in airway epithelium. Am J Respir Cell Mol Biol 2004;31:456–462.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    Gern JE, French DA, Grindle KA, Brockman-Schneider RA, Konno S, Busse WW. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. Am J Respir Cell Mol Biol 2003;28:731–737.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Uetani K, Arroliga ME, Erzurum SC. Double-stranded RNA dependence of nitric oxide synthase 2 expression in human bronchial epithelial cell BET-1 and BEAS-2B. Am J Respir Cell Mol Biol 2001;24:720–726.
    OpenUrlPubMed
  23. ↵
    Lemanske JRF. Viruses and asthma: inception, exacerbation, and possible prevention. J Pediatr 2003;142: Suppl. 2 S3–S8.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    Rylander E, Eriksson M, Pershagen G, Nordvall L, Ehrnst A, Ziegler T. Wheezing bronchitis in children. Incidence, viral infections, and other risk factors in a defined population. Pediatr Allergy Immunol 1996;7:6–11.
    OpenUrlPubMedWeb of Science
  25. Nicholson KG, Kent J, Hammersley V, Cancio E. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study. BMJ 1996;313:1119–1123.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Heymann PW, Carper HT, Murphy DD, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 2004;114:239–247.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    De Smedt A, Vanderlinden E, Demanet C, Waele DM, Goossens A, Noppen M. Characterization of pleural inflammation occurring after primary spontaneous pneumothorax. Eur Respir J 2004;23:896–900.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Greiff L, Venge P, Andersson M, et al. Effects of rhinovirus-induced common colds on granulocyte activity in allergic rhinitis. J Infect 2002;45:227–232.
    OpenUrlPubMed
  29. ↵
    Gessner A, Rollinghoff M. Biologic functions and signaling of the interleukin-4 receptor complexes. Immunobiology 1999;201:285–307.
    OpenUrl
  30. ↵
    Mozo L, Gayo A, Suarez A, Rivas D, Zamorano J, Gutierrez C. Gulucocorticoids inhibit IL–4 and mitogen-induced IL-4R alpha chain expression by different posttranscriptional mechanisms. J Allergy Clin Immunol 1998;102:968–976.
    OpenUrlCrossRefPubMedWeb of Science
  31. ↵
    Samuel CE. Antiviral actions of interferons. Clin Microbiol Reviews 2001;14:778–809.
  32. ↵
    Iordanov MS, Paranjape JM, Zhou A, et al. Activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase by double stranded-RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol 2000;20:617–627.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
View this article with LENS
Vol 26 Issue 5 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells
K. Tsuji, S. Yamamoto, W. Ou, N. Nishi, I. Kobayashi, M. Zaitsu, E. Muro, Y. Sadakane, T. Ichimaru, Y. Hamasaki
European Respiratory Journal Nov 2005, 26 (5) 795-803; DOI: 10.1183/09031936.05.00010805

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells
K. Tsuji, S. Yamamoto, W. Ou, N. Nishi, I. Kobayashi, M. Zaitsu, E. Muro, Y. Sadakane, T. Ichimaru, Y. Hamasaki
European Respiratory Journal Nov 2005, 26 (5) 795-803; DOI: 10.1183/09031936.05.00010805
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society